Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

fruit

- PMLiVE

Eisai and BioArctic sign research evaluation agreement for potential new Alzheimer’s treatment

AD is the most common form of dementia, which affects around 55 million people globally

- PMLiVE

Rare diseases – raising awareness, listening to patients, making a difference

PME speaks to Lorna Pender, Global Patient Engagement Lead at Clinigen, about the treatment options available to patients with rare diseases and the barriers that are hindering access

Black and white image of man and woman sitting at desk with laptop

Rebrand for Cheshire creative agency, LOVELIVE

Cheshire creative agency LOVELIVE has unveiled a new-look branding; coinciding with the launch of a new website as they celebrate 22% year on year growth and an exciting new focus.

LOVELIVE

- PMLiVE

Fox&Cat Relaunches With An Industry-First Efficiency & Effectiveness Planning Framework, ADAPTTM

F&C network team picture, March 2024 Fox&Cat relaunches today with its new people-first, senior consultant operating model and bespoke planning framework, ADAPTTM. The agency’s lean model...

Fox&Cat

- PMLiVE

Pfizer’s antibiotic combination receives EC approval to treat multidrug-resistant infections

Antimicrobial resistance has been declared by WHO as one of the top ten threats to global health

- PMLiVE

UCB’s Bimzelx granted EC approval to treat hidradenitis suppurativa in adults

The regulator’s decision marks Bimzelx’s fourth approved indication within the EU

- PMLiVE

Takeda’s subcutaneous Entyvio approved by FDA as Crohn’s disease maintenance therapy

Inflammatory bowel disease affects around ten million people worldwide

- PMLiVE

Afon Technology’s glucose monitoring device secures Junkosha award plus $25,000 prize

The company was presented with the award in recognition of its Glucowear device

- PMLiVE

Budget burnout: avoiding the pitfalls of outdated engagement strategies

By Jake Crute

- PMLiVE

Fox&Cat relaunches with industry-first efficiency and effectiveness planning framework ADAPT

ADAPT was created alongside in-house teams, a behaviour change expert and a well-being coach

- PMLiVE

Navigating the future of AI: Insights from EphMRA’s one day meeting in London

Authored by: Ellie Forde and Mark Braund, Directors

Research Partnership

- PMLiVE

Ipsen and Skyhawk announce $1.8bn partnership to advance rare neurological disease therapies

The agreement gives Ipsen an option to receive exclusive global rights to two candidates

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links